Back to Search
Start Over
Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes.
- Source :
-
European journal of haematology [Eur J Haematol] 2019 May; Vol. 102 (5), pp. 442-443. Date of Electronic Publication: 2019 Mar 13. - Publication Year :
- 2019
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Blood Transfusion
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myelodysplastic Syndromes diagnosis
Myelodysplastic Syndromes therapy
Treatment Outcome
Young Adult
Deferasirox therapeutic use
Iron Chelating Agents therapeutic use
Iron Overload drug therapy
Iron Overload etiology
Myelodysplastic Syndromes complications
Subjects
Details
- Language :
- English
- ISSN :
- 1600-0609
- Volume :
- 102
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- European journal of haematology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 30776156
- Full Text :
- https://doi.org/10.1111/ejh.13222